Clinical Trial

Multifactorial Intervention to Reduce Cardiovascular Disease in Type 1 Diabetes

Study acronym: Steno1
Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
A prospective, randomised, open-labelled, multi-center study. The aim of the Steno 1 study is to test multifactorial intervention in individuals with type 1 diabetes at high risk of CVD with ambitious treatment targets. We will include 2000 participants. Follow-up is 5 years.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2023-10-08.
Status change: Not Yet Recruiting → Recruiting 2025-01-08
Trial Details
NCT Number NCT06082063
Lead Sponsor Steno Diabetes Center Copenhagen
Collaborators: Aarhus University Hospital, Steno Diabetes Center Nordjylland, Steno Diabetes Center Odense, Slagelse Hospital, Nykøbing Falster County Hospital, Zealand University Hospital, Hillerod Hospital, Denmark, Rigshospitalet, Denmark, Hvidovre University Hospital, Regionshospitalet Viborg, Skive, Randers Regional Hospital, Herning Hospital, Esbjerg Hospital - University Hospital of Southern Denmark, Regionshospitalet Silkeborg, Bispebjerg Hospital, Regionshospitalet Horsens
Conditions Cardiovascular Diseases, Heart Failure, Type 1 Diabetes, Kidney Failure
Enrollment 2,000 participants
Start Date 2024-07-01
Primary Completion 2029-07-01 (estimated)
Study Completion 2029-07-01 (estimated)
Updated on ClinicalTrials.gov 2025-01-10